Main Article Content

Abstract

In this study, a series of new symmetrical N-carbothioamide substituted bispyrazolines (2a-f) had been systematically synthesized by using ring closure reactions of bischalcones (1a-f) with thiosemicarbazide under the alkaline-alcoholic conditions. The structures of bisheterocyclic products have been fully characterized on the basis of their IR, 1H & 13C NMR and ESI-MS spectral strategies. All the prepared compounds were also evaluated for their in vitro antimicrobial assay with the help of serial tube dilution procedure against the selected numbers of microbes (seven bacterial and five fungal strains). The most of the synthesized bisheterocycles exhibited noticeable antimicrobial potencies against the tested strains.

Keywords

Bischalcone N-Carbothioamide-bispyrazolines Aliphatic linkers Antimicrobial activity.

Article Details

How to Cite
Nisa, S., & Yusuf, M. (2020). Synthesis, Characterization & Antimicrobial Evaluation of New bis(5-Biphenyl-3-alkoxyphenyl-4,5-dihydro-1H-pyrazole-N-carbothioamide) Derivatives. Asian Journal of Organic & Medicinal Chemistry, 5(1), 77–83. https://doi.org/10.14233/ajomc.2020.AJOMC-P255

References

  1. P. Arora, V. Arora, S.H. Lamba and D. Wadhwa, Importance of Hetero-cyclic Chemistry: A Review, Int. J. Pharm. Sci. Res., 3, 2947 (2012); https://doi.org/10.13040/IJPSR.0975-8232.3(9).2947-54
  2. T. Torroba, Poly-Sulfur-Nitrogen Heterocycles via Sulfur Chlorides and Nitrogen Reagents, J. Prakt. Chem., 341, 99 (1999); https://doi.org/10.1002/(SICI)1521-3897(199902)341:2<99::AID-PRAC99>3.0.CO;2-Z
  3. R. Dua, S. Shrivastava, S.K. Sonwane and S.K. Srivastava, Pharmaco-logical Significance of Synthetic Heterocycles Scaffold: A Review, Adv. Biol. Res. (Faisalabad), 5, 120 (2011).
  4. S.B.A. Halkes, I. Vrasidas, G.R. Rooijer, A.J.J. van den Berg, R.M.J. Liskamp and R.J. Pieters, Synthesis and Biological Activity of Polygalloyl-Dendrimers as Stable Tannic Acid Mimics, Bioorg. Med. Chem. Lett., 12, 1567 (2002); https://doi.org/10.1016/S0960-894X(02)00245-7
  5. L.D. Quin and J.A. Tyrell, Fundamentals of Heterocyclic Chemistry: Importance in Nature & in the Synthesis of Pharmaceuticals, John Wiley & Sons (2010).
  6. C.T. Walsh, Nature Loves Nitrogen Heterocycles, Tetrahedron Lett., 56, 3075 (2015); https://doi.org/10.1016/j.tetlet.2014.11.046
  7. M. Garcia-Valverde and T. Torroba, Sulfur-Nitrogen Heterocycles, Molecules, 10, 318 (2005); https://doi.org/10.3390/10020318
  8. R. Neama, N.M. Aljamali and M. Jari, Synthesis, Identification of Hetero-cyclic Compounds and Study of Biological Activity, Asian J. Res. Chem, 7, 664 (2014).
  9. J. Alvarez-Builla, J.J. Vaquero and J. Barluenga, Modern Heterocyclic Chemistry, John Wiley & Sons, vol. 49, Set II (2011).
  10. M.S. Saini, A. Kumar, J. Dwivedi and R. Singh, A Review: Biological Significances of Heterocyclic Compounds, Int. J. Pharm. Sci. Res., 4, 66 (2013).
  11. M.F. Khan, M.M. Alam, G. Verma, W. Akhtar, M. Shaquiquzzaman and M. Akhter, The Therapeutic Voyage of Pyrazole and its Analogs: A Review, Eur. J. Med. Chem., 120, 170 (2016); https://doi.org/10.1016/j.ejmech.2016.04.077
  12. V.D. Joshi, M.D. Kshirsagar and S. Sarita, Synthesis and Antimicrobial Activities of Various Pyrazolines from Chalcones, Int. J. Chem.Tech. Res., 4, 971 (2012).
  13. S.B. Annes, R. Rajmohan, S. Ramesh and P. Vairaprakash, Visible Light Mediated Metal-Free Oxidative Aromatization of 1,3,5-Trisubstituted Pyrazolines, Tetrahedron Lett., 60, 150932 (2019); https://doi.org/10.1016/j.tetlet.2019.07.023
  14. S.G. Kucukguzel and S. Senkardes, Recent Advances in Bioactive Pyrazoles, Eur. J. Med. Chem., 97, 786 (2015); https://doi.org/10.1016/j.ejmech.2014.11.059
  15. V. Kumar, K. Kaur, G.K. Gupta and A.K. Sharma, Pyrazole Containing Natural Products: Synthetic Preview and Biological Significance, Eur. J. Med. Chem., 69, 735 (2013); https://doi.org/10.1016/j.ejmech.2013.08.053
  16. N.M. Stefanes, J. Toigo, M.F. Maioral, A.V. Jacques, L.D. Chiaradia-Delatorre, D.M. Perondi, A.A.B. Ribeiro, Á. Bigolin, I.M.S. Pirath, B.F. Duarte, R.J. Nunes and M.C. Santos-Silva, Synthesis of Novel Pyrazoline Derivatives and the Evaluation of Death Mechanisms Involved in their Antileukemic Activity, Bioorg. Med. Chem. Lett., 27, 375 (2019); https://doi.org/10.1016/j.bmc.2018.12.012
  17. J. He, L. Ma, Z. Wei, J. Zhu, F. Peng, M. Shao, L. Lei, L. He, M. Tang, L. He, Y. Wu and L. Chen, Synthesis and Biological Evaluation of Novel Pyrazoline Derivatives as Potent Anti-inflammatory Agents, Bioorg. Med. Chem. Lett., 25, 2429 (2015); https://doi.org/10.1016/j.bmcl.2015.03.087
  18. S. Bawa, N. Goel, S. Drabu and O. Afzal, Antimicrobial Screening and One-pot Synthesis of 4-(Substituted-anilinomethyl)-3-(2-naphthyl)-1-phenyl-1H-pyrazole Derivatives, J. Pharm. Bioallied Sci., 6, 253 (2014); https://doi.org/10.4103/0975-7406.142956
  19. N. Devi, R. Shankar and V. Singh, 4-Formyl-Pyrazole-3-Carboxylate: A Useful Aldo-X Bifunctional Precursor for the Syntheses of Pyrazole-fused/Substituted, J. Heterocycl. Chem., 55, 373 (2018); https://doi.org/10.1002/jhet.3045
  20. J. Elguero, P. Goya, N. Jagerovic and A.M.S. Silva, Targets in Heterocyclic Systems, Italian Society of Chemistry: Roma, vol. 6, p. 52 (2002).
  21. M. Asif, A Mini Review: Biological Significances of Nitrogen Hetero Atom Containing Heterocyclic Compounds, Int. J. Bioorg. Chem., 2, 146 (2017).
  22. J.M. López-Plá, A.K. Boudalis, J. Telser and R.G. Raptis, Chromium(III)-Pyrazole Complexes. X-Ray Crystal Structures, 1H NMR Investigation of Ligand Fluxional Behavior and EPR Studies, Inorg. Chim. Acta, 502, 119299 (2020); https://doi.org/10.1016/j.ica.2019.119299
  23. W. Yu, Z.-W. Zhai, D.E. Wedge, S.O. Duke, H.-K. Wu, J.-Q. Weng, C.-X. Tan, Y.-G. Zhang and X.-H. Liu, Synthesis and Biological Activity of Novel 1,3,4-oxadiazole Derivatives Containing a Pyrazole Moiety, Res. Chem. Intermed., 45, 5989 (2019); https://doi.org/10.1007/s11164-019-04015-8
  24. D. Havrylyuk, B. Zimenkovsky, O. Vasylenko and R. Lesyk, Synthesis and Anticancer and Antiviral Activities of New 2-Pyrazoline-Substituted 4-Thiazolidinones, J. Heterocycl. Chem., 50(S1), E55 (2013); https://doi.org/10.1002/jhet.1056
  25. M.M. Almahdi, A.E.M. Saeed and N.H. Metwally, Synthesis and Antimicrobial Activity of Some New Pyrazoline Derivatives Bearing Sulfanilamido Moiety, Eur. J. Chem., 10, 30 (2019); https://doi.org/10.5155/eurjchem.10.1.30-36.1791
  26. Y.R. Prasad, A.L. Rao, L. Prasoona, K. Murali and P.R. Kumar, Synthesis and Antidepressant Activity of Some 1,3,5-triphenyl-2-pyraz-olines and 3-(2¢-Hydroxynaphthalen-1¢-yl)-1,5-diphenyl-2-pyrazolines, Bioorg. Med. Chem. Lett., 15, 5030 (2005); https://doi.org/10.1016/j.bmcl.2005.08.040
  27. M. Amir, H. Kumar and S.A. Khan, Synthesis and Pharmacological Evaluation of Pyrazoline Derivatives as New Anti-inflammatory and Analgesic Agents, Bioorg. Med. Chem. Lett., 18, 918 (2008); https://doi.org/10.1016/j.bmcl.2007.12.043
  28. D. Havrylyuk, B. Zimenkovsky, O. Vasylenko, A. Gzella and R. Lesyk, Synthesis of New 4-Thiazolidinone-, Pyrazoline- and Isatin-Based Conjugates with Promising Antitumor Activity, J. Med. Chem., 55, 8630 (2012); https://doi.org/10.1021/jm300789g
  29. R.A. Nugent, M. Murphy, S.T. Schlachter, C.J. Dunn, R.J. Smith, N.D. Staite, L.A. Galinet, S.K. Shields, D.G. Aspar, K.A. Richard and N.A. Rohloff, Pyrazoline Bisphosphonate Esters as Novel Antiinflammatory and Antiarthritic Agents, J. Med. Chem., 36, 134 (1993); https://doi.org/10.1021/jm00053a017
  30. M. Shaharyar, M.M. Abdullah, M.A. Bakht and J. Majeed, Pyrazoline Bearing Benzimidazoles: Search for Anticancer Agent, Eur. J. Med. Chem., 45, 114 (2010); https://doi.org/10.1016/j.ejmech.2009.09.032
  31. Z. Ozdemir, H.B. Kandilci, B. Gumusel, U. Calis and A.A. Bilgin, Synthesis and Studies on Antidepressant and Anticonvulsant Activities of Some 3-(2-Furyl)pyrazoline Derivatives, Eur. J. Med. Chem., 42, 373 (2007); https://doi.org/10.1016/j.ejmech.2006.09.006
  32. S.U.F. Rizvi, H.L. Siddiqui, M. Johns, M. Detorio and R.F. Schinazi, Anti-HIV-1 and Cytotoxicity Studies of Piperidyl-Thienyl Chalcones and their 2-Pyrazoline Derivatives, Med. Chem. Res., 21, 3741 (2012); https://doi.org/10.1007/s00044-011-9912-x
  33. A.E.G.E. Amr, M. A. AL-OMAR and M. M. Abdalla, Anti-Inflammatory and Antipyretic Activities of Some Thiopyrimidine, Pyrazoline and Thiazolopyrimidine Derivatives, Lat. Am. J. Pharm., 35, 950 (2016).
  34. Z. Brzozowski, S. Angielski and C. Wojcikowski, 2-Pyrazoline-1-carbox-amide Sulfonamide Derivatives useful as Hypoglycemic Agents, U.S. Patent 3,887,709 (1975).
  35. O.D. Can, U.D. Ozkay, Z.A. Kaplancikli and Y. Ozturk, Effects of Some 1,3,5-Trisubstitued-2-pyrazoline Derivatives on Depression and Anxiety Parameters of Mice, Arch. Pharm. Res., 32, 1293 (2009); https://doi.org/10.1007/s12272-009-1915-5
  36. M. Yusuf and I. Solanki, Synthesis and Antimicrobial Studies of Furyl Based New Bispyrazolines Linked via Aliphatic Chains, J. Saudi Chem. Soc., 21, 251 (2017); https://doi.org/10.1016/j.jscs.2015.02.002
  37. M. Yusuf and M. Kaur, Synthesis and Antimicrobial Evaluations of New 5-aryl Linked Bispyrazolines, J. Heterocycl. Chem., 54, 735 (2017); https://doi.org/10.1002/jhet.2583
  38. M. Yusuf and S. Thakur, Multicomponent Synthesis of New bis(Pyran-pyrazole) and their Antimicrobial-Antioxidant Evaluations, J. Serb. Chem. Soc., 84, 119 (2019); https://doi.org/10.2298/JSC171107074Y
  39. M. Yusuf and S. Thakur, Synthesis and Applications of Bisheterocyclic Compounds, Curr. Org. Synth., 15, 603 (2018); https://doi.org/10.2174/1570179415666180405121737
  40. M. Yusuf and P. Jain, Synthetic and Biological Studies of Pyrazolines and Related Heterocyclic Compounds, Arab. J. Chem., 7, 553 (2014); https://doi.org/10.1016/j.arabjc.2011.09.013
  41. M. Yusuf, S. Nisa and K. Paul, New Biphenyl-Based Bispyrazolines: Synthesis, Antimicrobial and Docking Studies, J. Heterocycl. Chem., 56, 2659 (2019); https://doi.org/10.1002/jhet.3631
  42. P.K. Sarvesh and K. Nizamuddin, Synthesis and Antimicrobial Study of Novel 1-Aryl-2-oxo-indano[3,2-d]pyrido/pyrimido[1,2-b]pyrimidines, Arch. Pharm. Chem. Life Sci., 341, 418 (2008); https://doi.org/10.1002/ardp.200700197